301 related articles for article (PubMed ID: 16646062)
21. Real-world experiences of folic acid supplementation (5 versus 30 mg/week) with methotrexate in rheumatoid arthritis patients: a comparison study.
Koh KT; Teh CL; Cheah CK; Ling GR; Yong MC; Hong HC; Gun SC
Reumatismo; 2016 Sep; 68(2):90-6. PubMed ID: 27608797
[TBL] [Abstract][Full Text] [Related]
22. Folate supplementation during methotrexate treatment of patients with rheumatoid arthritis. An update and proposals for guidelines.
Endresen GK; Husby G
Scand J Rheumatol; 2001; 30(3):129-34. PubMed ID: 11469521
[TBL] [Abstract][Full Text] [Related]
23. Comment on: Methotrexate pharmacogenomics in rheumatoid arthritis: introducing false positive report probability.
Beretta L
Rheumatology (Oxford); 2009 Dec; 48(12):1619-20; author reply 1620. PubMed ID: 19828599
[No Abstract] [Full Text] [Related]
24. Limitations of the study of subcutaneous versus oral administration of methotrexate in patients with active rheumatoid arthritis: comment on the article by Braun et al.
Raghu P; Grover PS; Kumar A
Arthritis Rheum; 2008 Jul; 58(7):2209; author reply 2209-10. PubMed ID: 18576338
[No Abstract] [Full Text] [Related]
25. Myelotoxicity due to methotrexate - an iatrogenic cause.
Saravana S; Lalukotta K
Eur J Haematol; 2003 Oct; 71(4):315-6. PubMed ID: 12950246
[No Abstract] [Full Text] [Related]
26. [Methotrexate: mainstay of rheumatoid arthritis treatment].
Jacobs JW; Bijlsma JW
Ned Tijdschr Geneeskd; 2009; 153():A879. PubMed ID: 19785862
[TBL] [Abstract][Full Text] [Related]
27. Folate supplementation and methotrexate.
Houtman PM
Br J Rheumatol; 1996 Oct; 35(10):1031-2. PubMed ID: 8883449
[No Abstract] [Full Text] [Related]
28. Acute erythroleukemia in a rheumatoid arthritis patient during low-dose methotrexate therapy.
Choi BR; Ahn MJ; Lee WS; Kim TH; Bae SC; Jun JB
Rheumatol Int; 2005 May; 25(4):311-3. PubMed ID: 15338190
[TBL] [Abstract][Full Text] [Related]
29. Understanding the mechanisms of action of methotrexate: implications for the treatment of rheumatoid arthritis.
Tian H; Cronstein BN
Bull NYU Hosp Jt Dis; 2007; 65(3):168-73. PubMed ID: 17922664
[TBL] [Abstract][Full Text] [Related]
30. [Treatment of rheumatoid arthritis: 200 recommendations on the use of methotrexate].
Durand S
Perspect Infirm; 2009; 6(3):33-4. PubMed ID: 20120318
[No Abstract] [Full Text] [Related]
31. Effects of methotrexate use in a patient with rheumatoid arthritis and multiple sclerosis.
Li S; Kaur PP; Berney SN
J Clin Rheumatol; 2008 Aug; 14(4):241-2. PubMed ID: 18766127
[TBL] [Abstract][Full Text] [Related]
32. Comment on: 'comparison of Tripterygium wilfordii Hook F with methotrexate in the treatment of active rheumatoid arthritis (TRIFRA): a randomised, controlled clinical trial' by Qian-wen et al.
Landewé RB; van der Heijde D
Ann Rheum Dis; 2014 Oct; 73(10):e62. PubMed ID: 25013090
[No Abstract] [Full Text] [Related]
33. Common polymorphisms in the folate pathway predict efficacy of combination regimens containing methotrexate and sulfasalazine in early rheumatoid arthritis.
James HM; Gillis D; Hissaria P; Lester S; Somogyi AA; Cleland LG; Proudman SM
J Rheumatol; 2008 Apr; 35(4):562-71. PubMed ID: 18322994
[TBL] [Abstract][Full Text] [Related]
34. [Is the guideline, "Management of early rheumatoid arthritis," being followed in a rheumatism center?].
Hartmann M; Gundermann C; Richter A; Eidner T; Hein G
Dtsch Med Wochenschr; 2008 Aug; 133(34-35):1721-4. PubMed ID: 18696403
[TBL] [Abstract][Full Text] [Related]
35. Early rheumatoid arthritis: combination therapy of doxycycline plus methotrexate versus methotrexate monotherapy.
Alarcón GS
Nat Clin Pract Rheumatol; 2006 Jun; 2(6):296-7. PubMed ID: 16932705
[No Abstract] [Full Text] [Related]
36. Right on target: coupling methotrexate to albumin to treat rheumatoid arthritis.
Elewaut D
Rheumatology (Oxford); 2004 Sep; 43(9):1067-8. PubMed ID: 15187243
[No Abstract] [Full Text] [Related]
37. Do patients with rheumatoid arthritis established on methotrexate and folic acid 5 mg daily need to continue folic acid supplements long term?
Griffith SM; Fisher J; Clarke S; Montgomery B; Jones PW; Saklatvala J; Dawes PT; Shadforth MF; Hothersall TE; Hassell AB; Hay EM
Rheumatology (Oxford); 2000 Oct; 39(10):1102-9. PubMed ID: 11035130
[TBL] [Abstract][Full Text] [Related]
38. Inclusion of glucocorticoids in recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis: Comment on the article by Saag et al.
van Tuyl LH; Lems WF; Voskuyl AE; Dijkmans BA; Boers M; Kerstens PJ
Arthritis Rheum; 2009 Jan; 61(1):141-2; author reply 141-2. PubMed ID: 19116962
[No Abstract] [Full Text] [Related]
39. Trials in rheumatoid arthritis: choosing the right outcome measures--comment on the article by Felson et al.
Porter D
Ann Rheum Dis; 2008 Sep; 67(9):1356. PubMed ID: 18697785
[No Abstract] [Full Text] [Related]
40. An audit of methotrexate and folic acid for rheumatoid arthritis. Experience from a teaching centre.
Jobanputra P; Hunter M; Clark D; Lambert CM; Hurst NP
Br J Rheumatol; 1995 Oct; 34(10):971-5. PubMed ID: 7582706
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
